logo

For the Inventor, By the Inventor

Toyonaka, Japan

Akihiko Sugie

This inventor holds 10 USPTO granted patents. Top assignee: Sumitomo Chemical Company, Limited. Active years: 1978-1987.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Akihiko Sugie. Retrieved from https://idiyas.com/inventor/akihiko-sugie

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10

% Patents Active = 100.0

Average Co-Inventor Count = 4.1

ph-index = 3

Forward Citations = 35(Granted Patents)


Location History:

  • Takarazuka, JA (1978)
  • Takarazuka, JP (1978 - 1980)
  • Hyogo, JP (1982)
  • Toyonaka, JP (1981 - 1987)

Company Filing History:

goldMedal10 out of 6,960 
 
Sumitomo Chemical Company, Limited
 patents

Years Active: 1978-1987

Loading Chart...
10 patents (USPTO):Explore Patents
1. 4680307 - Carbacyclin analogs (1987-07-14),
2. 4537989 - Imino-bicyclo (3.3.0) octane derivatives (1985-08-27),
3. 4493846 - Bicyclooctane derivatives (1985-01-15),
4. 4400393 - Novel bicyclooctane compounds (1983-08-23),
5. 4347254 - Tricyclic cage compounds, their synthesis and use as antiviral agents (1982-08-31),
6. 4292432 - Novel aldol derivatives and production thereof (1981-09-29),
7. 4233222 - Cyclopentylacetic acid derivatives (1980-11-11),
8. 4210669 - Prostanoic acid derivatives (1980-07-01),
9. 4125731 - Novel indan derivatives (1978-11-14),
10. 4073933 - Novel bicycloheptene derivatives (1978-02-14),

Title: Akihiko Sugie: Innovator in Pharmaceutical Chemistry

Introduction

Akihiko Sugie is a prominent inventor based in Toyonaka, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds with therapeutic applications. With a total of 10 patents to his name, Sugie's work has had a notable impact on medical science.

Latest Patents

Among his latest innovations are the Carbacyclin analogs, which are compounds designed to exhibit strong anti-ulcerous and antithrombotic actions. These compounds are useful in the treatment of ulcers and thrombosis. Another significant patent involves Imino-bicyclo (3.3.0) octane derivatives, which demonstrate strong anti-cancer activity and are beneficial in cancer treatment. These inventions highlight Sugie's commitment to addressing critical health issues through innovative chemical solutions.

Career Highlights

Sugie is associated with Sumitomo Chemical Company, Limited, where he has been instrumental in advancing research and development in pharmaceutical compounds. His expertise in synthesizing complex chemical structures has positioned him as a key figure in his field.

Collaborations

He has collaborated with notable colleagues, including Junki Katsube and Hiromi Shimomura, to further enhance the scope and impact of their research endeavors.

Conclusion

Akihiko Sugie's contributions to pharmaceutical chemistry through his innovative patents reflect his dedication to improving health outcomes. His work continues to inspire advancements in medical treatments and therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…